These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 7634391

  • 1. Non-genotoxic hepatocarcinogens stimulate DNA synthesis and their withdrawal induces apoptosis, but in different hepatocyte populations.
    Roberts RA, Soames AR, Gill JH, James NH, Wheeldon EB.
    Carcinogenesis; 1995 Aug; 16(8):1693-8. PubMed ID: 7634391
    [Abstract] [Full Text] [Related]

  • 2. The peroxisome proliferator class of non-genotoxic hepatocarcinogens synergize with epidermal growth factor to promote clonal expansion of initiated rat hepatocytes.
    James NH, Roberts RA.
    Carcinogenesis; 1994 Dec; 15(12):2687-94. PubMed ID: 8001222
    [Abstract] [Full Text] [Related]

  • 3. The rodent non-genotoxic hepatocarcinogen nafenopin suppresses apoptosis preferentially in non-cycling hepatocytes but also elevates CDK4, a cell cycle progression factor.
    Gill JH, Brickell P, Dive C, Roberts RA.
    Carcinogenesis; 1998 Oct; 19(10):1743-7. PubMed ID: 9806153
    [Abstract] [Full Text] [Related]

  • 4. Species differences in response to peroxisome proliferators correlate in vitro with induction of DNA synthesis rather than suppression of apoptosis.
    James NH, Roberts RA.
    Carcinogenesis; 1996 Aug; 17(8):1623-32. PubMed ID: 8761418
    [Abstract] [Full Text] [Related]

  • 5. Dosing-induced stress causes hepatocyte apoptosis in rats primed by the rodent nongenotoxic hepatocarcinogen cyproterone acetate.
    Roberts RA, Soames AR, James NH, Gill JH, Wheeldon EB.
    Toxicol Appl Pharmacol; 1995 Dec; 135(2):192-9. PubMed ID: 8545827
    [Abstract] [Full Text] [Related]

  • 6. Reduced expression of mature TGF beta 1 correlates with the suppression of rat hepatocyte apoptosis by the peroxisome proliferator, nafenopin.
    Strange J, Roberts RA.
    Mutat Res; 1996 Nov 11; 372(1):107-13. PubMed ID: 9003537
    [Abstract] [Full Text] [Related]

  • 7. The peroxisome proliferator nafenopin does not suppress hepatocyte apoptosis in guinea-pig liver in vivo nor in human hepatocytes in vitro.
    Hasmall SC, James NH, Soames AR, Roberts RA.
    Arch Toxicol; 1998 Dec 11; 72(12):777-83. PubMed ID: 9950074
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Quantitation of apoptotic bodies in rat liver by in situ end labelling (ISEL): correlation with morphology.
    Wheeldon EB, Williams SM, Soames AR, James NH, Roberts RA.
    Toxicol Pathol; 1995 Dec 11; 23(3):410-5. PubMed ID: 7659962
    [Abstract] [Full Text] [Related]

  • 12. The non-genotoxic hepatocarcinogen nafenopin suppresses rodent hepatocyte apoptosis induced by TGFbeta1, DNA damage and Fas.
    Gill JH, James NH, Roberts RA, Dive C.
    Carcinogenesis; 1998 Feb 11; 19(2):299-304. PubMed ID: 9498280
    [Abstract] [Full Text] [Related]

  • 13. Role of hepatic non-parenchymal cells in the response of rat hepatocytes to the peroxisome proliferator nafenopin in vitro.
    Hasmall SC, West DA, Olsen K, Roberts RA.
    Carcinogenesis; 2000 Dec 11; 21(12):2159-65. PubMed ID: 11133804
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Non-genotoxic hepatocarcinogenesis in vitro: the FaO hepatoma line responds to peroxisome proliferators and retains the ability to undergo apoptosis.
    Bayly AC, French NJ, Dive C, Roberts RA.
    J Cell Sci; 1993 Feb 11; 104 ( Pt 2)():307-15. PubMed ID: 8389374
    [Abstract] [Full Text] [Related]

  • 16. Non-genotoxic hepatocarcinogenesis: suppression of apoptosis by peroxisome proliferators.
    Roberts RA.
    Ann N Y Acad Sci; 1996 Dec 27; 804():588-611. PubMed ID: 8993575
    [No Abstract] [Full Text] [Related]

  • 17. Growth, regression and cell death in rat liver as related to tissue levels of the hepatomitogen cyproterone acetate.
    Bursch W, Düsterberg B, Schulte-Hermann R.
    Arch Toxicol; 1986 Dec 27; 59(4):221-7. PubMed ID: 2435263
    [Abstract] [Full Text] [Related]

  • 18. Mouse hepatocyte response to peroxisome proliferators: dependency on hepatic nonparenchymal cells and peroxisome proliferator activated receptor alpha (PPARalpha).
    Hasmall S, James N, Hedley K, Olsen K, Roberts R.
    Arch Toxicol; 2001 Aug 27; 75(6):357-61. PubMed ID: 11570693
    [Abstract] [Full Text] [Related]

  • 19. Effects of non-genotoxic hepatocarcinogens phenobarbital and nafenopin on phenotype and growth of different populations of altered foci in rat liver.
    Schulte-Hermann R, Kraupp-Grasl B, Bursch W, Gerbracht U, Timmermann-Trosiener I.
    Toxicol Pathol; 1989 Aug 27; 17(4 Pt 1):642-9; discussion 649-50. PubMed ID: 2576472
    [Abstract] [Full Text] [Related]

  • 20. Role for tumor necrosis factor alpha receptor 1 and interleukin-1 receptor in the suppression of mouse hepatocyte apoptosis by the peroxisome proliferator nafenopin.
    West DA, James NH, Cosulich SC, Holden PR, Brindle R, Rolfe M, Roberts RA.
    Hepatology; 1999 Dec 27; 30(6):1417-24. PubMed ID: 10573520
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.